EP 2167059 A2 20100331 - NOVEL PROLACTIN COMPOUNDS
Title (en)
NOVEL PROLACTIN COMPOUNDS
Title (de)
NEUARTIGE PROLACTINVERBINDUNGEN
Title (fr)
NOUVEAUX COMPOSÉS DE PROLACTINE
Publication
Application
Priority
- EP 2008058593 W 20080703
- EP 07111799 A 20070705
- EP 2007007863 W 20070910
- EP 08388007 A 20080209
- EP 08101470 A 20080211
- EP 08101589 A 20080213
- EP 08802942 A 20080703
Abstract (en)
[origin: WO2009004058A2] The present invention relates to prolactin analogues, which analogues have increased resistance to deamidation.
IPC 8 full level
A61K 31/00 (2006.01); C07K 14/575 (2006.01)
CPC (source: EP)
C07K 14/57554 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 2009004058A2
Citation (examination)
GOFFIN VINCENT ET AL: "Development and potential clinical uses of human prolactin receptor antagonists", ENDOCRINE REVIEWS, THE ENDOCRINE SOCIETY, US, vol. 26, no. 3, 1 May 2005 (2005-05-01), pages 400 - 422, XP002604925, ISSN: 0163-769X, [retrieved on 20050406], DOI: 10.1210/ER.2004-0016
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
WO 2009004058 A2 20090108; WO 2009004058 A3 20090312; EP 2167059 A2 20100331
DOCDB simple family (application)
EP 2008058593 W 20080703; EP 08802942 A 20080703